Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...
Reexamination Certificate
2008-04-29
2008-04-29
Marschel, Ardin H. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Acyclic nitrogen double bonded to acyclic nitrogen, acyclic...
Reexamination Certificate
active
07365060
ABSTRACT:
The present invention is related to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of Formula I or a naked ligand of formula II: (Formula I and II).
REFERENCES:
patent: 6765104 (2004-07-01), Brechbiel et al.
Cecil (Textbook of Medicine, 21st Edition (2000), Goldman & Bennett (Editors), W.B. Saunders Company (Publisher), Chapter 198, pp. 1060-1074).
Lucchese B, et al. “Mono-, Bi-, and Trinclear Cull-CI containing products based on . . . ,” 2004 Inorganic Chem 43(19): 5987-5998.
Lee, Dong-Heon, et al. (“Binuclear Copper Complexes based on the 6,6′-Bis[[bis(2-pyridylmethyl)amino]methyl]-2,2′-bipyridine Ligand,” 1997 Inorganic Chem 36: 5785-5792).
Lee, Dong-Heon, et al. (“Reversible O2 binging to a dinuclear copper(I) complex with linked tris(2-pyridylmethyl)amine units,” 1995 JACS 117: 12498-12513).
Humphreys KJ, et al., “Targeted strand scission of DNA substrates by a Tricopper(II) coordination complex,” 2002 JACS 124: 8055-8066 (provided on PTO From 1449).
Humphreys KJ, et al., “Recognition and strand scission at junctions between single- and double-stranded DNA by a trinuclear copper complex,” 2001 JACS 123: 5588-5589 (provided on PTO From 1449).
“The CDER Handbook” Produced by the Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research <http://www.fda.gov/cder/handbook>, pp. 1-9, printed from the internet on Sep. 14, 2005.“The CDER Handbook”.
Gura et al. Systems for Identifying New Drugs are Often Faulty. Science, 1997, 278:1041-1042.
Johnson et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. British J. of Cancer, 2001, 84(10):1424-1431.
Kristi J. Humphreys et al; Recognition and Strand Scission at Junctions between Single-and Double-Stranded DNA by a Trinuclear Copper Complex; J. Am. Chem. Soc.; vol. 123; No. 23; 2001; pp. 5588-5589.
Kristi J. Humphreys et al; Targeted Strand Scission of DNA Substrates by a Tricopper (II) Coordination Complex; J. Am. Chem. Soc.; vol. 124; No. 27; 2001; pp. 8055-8066.
Kristi J. Humphreys et al; Efficient and Specific Strand Scission of DNA by a Dinuclear Copper Complex: Comparative Reactivity of Complexes with Linked Tris(2-pyridylmethyl)amine Moieties; J. Am. Chem. Soc. 2002; vol. 124; pp. 6009-6019.
Humphreys Kristi J.
Karlin Kenneth D.
Li Lei
Murthy Narasimha N.
Rokita Steven E.
Anderson James D.
Arent & Fox LLP
Marschel Ardin H.
University of Maryland
LandOfFree
Dinuclear copper-based compound and ligand for nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dinuclear copper-based compound and ligand for nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dinuclear copper-based compound and ligand for nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2772458